Not Signed In - United Research Laboratories/Mutual Pharmaceutical Company Announce ANDA Filing For Guaifenesin Extended-Release Tablets, 600 Mg And 1200 Mg
Sat, 19 Aug 2006 07:00 AM EST
... United Research Laboratories andMutual Pharmaceutical Company today announce that Mutual has filed anAbbreviated New Drug Application (ANDA) with the Food and DrugAdministration (FDA), seeking approval to market Mutual's guaifenesinextended-release tablets, 600 mg and 1200 mg. [click link for full article] ...
Related Topics
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Niacin Extended Release
- Research
- Bupropion Extended-Release
- Guaifenesin
- Understanding Medical Research
- Guaifenesin and Dextromethorphan
- Perindopril
- Amoxicillin and Clavulanate Potassium
- Guaifenesin and Hydrocodone
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Prometrium
- Lovastatin Extended Release
- Risedronate
- Isradipine Extended-Release Tablets
- Theophylline ER
- Phendimetrazine
- Calcium Carbonate Tablets
- Azithromycin
- Metoprolol ER
email this page
print this page
bookmark this page
feedback on this page
